Mclean Hospital

Pharmacology Related Content


Ross J. Baldessarini, MD

A career investigator of the NIMH from 1970 to 2001, Ross J. Baldessarini, MD, is an internationally known research psychopharmacologist with many contributions to the actions of antipsychotic and mood-altering medicines and has trained over 160 laboratory and clinical investigators. He joined McLean in 1977 to help establish and direct the McLean-Mailman Laboratories for Psychiatric Research. In...

J. Alexander Bodkin, MD

J. Alexander Bodkin, MD, has been at McLean since 1985. Working with Dr. Jonathan Cole until his death, Dr. Bodkin has long pursued the study of new and old medications for depression and anxiety. His research has focused on underutilized pharmacologic approaches to difficult-to-treat mood and anxiety disorders, such as MAO inhibitors, stimulants, and the opioid buprenorphine. Dr. Bodkin directs...

S. Barak Caine, PhD

S. Barak Caine, PhD, began his career as a research technician in the laboratory of Dr. Andrew Winokur at the University of Pennsylvania, before receiving pre-doctoral training in the laboratories of Dr. Mark Geyer at the University of California, and Dr. George Koob at The Scripps Research Institute, with whom Dr. Caine conducted his PhD thesis. Dr. Caine trained as a post-doctoral fellow at...

Franca Centorrino, MD

Franca Centorrino, MD, oversees a multidisciplinary team of clinicians treating outpatients with schizophrenia or bipolar disorder. Her research activities focus on the use of psychotropic medications for the treatment of schizophrenia and bipolar disorder and the management of side effects associated with these medications. Dr. Centorrino also supervises psychiatric residents and research...

Elena H. Chartoff, PhD

Elena H. Chartoff, PhD, is an assistant professor of psychiatry at Harvard Medical School and director of the Neurobiology of Motivated Behavior Laboratory at McLean Hospital. She is interested in the neurobiological mechanisms that connect depression and anxiety with drug addiction. The work in her laboratory has broad implications for understanding basic brain mechanisms that control mood and...

Rajeev I. Desai, PhD

Rajeev I. Desai, PhD, is an assistant professor of psychiatry at Harvard Medical School. He received his PhD from University of Birmingham, UK, before completing post-doctoral training at the National Institute on Drug Abuse. Dr. Desai joined the Preclinical Pharmacology Program (directed by Dr. Jack Bergman) at McLean Hospital in 2006. Dr. Desai’s research involves the use of behavioral...

Elif Engin, PhD

Elif Engin, PhD, grew up in Ankara, Turkey, and earned her undergraduate and master’s degrees at Middle East Technical University (METU) in Ankara. She completed her doctoral work in the laboratory of Dr. Dallas Treit in Edmonton, Alberta, and was awarded a PhD Thesis Award from the Canadian Psychological Association. Dr. Engin joined the Laboratory of Genetic Neuropharmacology at McLean...

Brian D. Kangas, PhD

Brian D. Kangas, PhD, first studied behavioral pharmacology under the direction of Dr. Marc Branch at the University of Florida followed by a post-doctoral fellowship under the direction of Dr. Jack Bergman at McLean Hospital. He is the recipient of several research awards including a 5-year K01 award from the National Institute on Drug Abuse and the 2014 B. F. Skinner New Researcher Award from...

Stephen J. Kohut, PhD

Stephen J. Kohut, PhD, focuses his research primarily on two main interacting lines of investigation: understanding how alterations in underlying neurobiology alter behavioral responses to drug administration, especially stimulants, and medications discovery for drug abuse and addiction. Dr. Kohut’s current research, funded by the National Institute on Drug Abuse, combines behavioral...

Jing Liu, PhD

Jing Liu, PhD, received his PhD degree in medicinal chemistry from the Academy of Military Medical Sciences in China. He has accumulated over 12 years of research experience in medicinal chemistry, especially in drug research and development. Dr. Liu has been a post-doctoral fellow at McLean Hospital since he joined the Bio-Organic and Natural Products Research Laboratory in 2012. He has served...

Natalia V. Luchkina, PhD

Natalia V. Luchkina, PhD, received her PhD degree from the University of Helsinki in Finland. During her graduate studies, Dr. Luchkina explored a developmental profile of mechanisms underlying the induction and expression of long-term-potentiation at CA3-CA1 synapses in the hippocampus. Her results linked the expression of GluA4 subunits of the AMPA receptor to alterations in signaling...

Scott E. Lukas, PhD

Scott E. Lukas received his PhD in pharmacology and toxicology in 1979 from the University of Maryland. After a post-doctoral fellowship at Johns Hopkins University, he joined NIDA Addiction Research Center for 18 months before moving to McLean in 1984. Promoted to professor in 2003, Dr. Lukas directs the McLean Imaging Center, the Behavioral Psychopharmacology Research Laboratory, and a NIDA T32...

John L. Neumeyer, PhD

John L. Neumeyer, PhD, received his BS from Columbia University, and PhD in medicinal chemistry from the University of Wisconsin, Madison. He became a professor of medicinal chemistry and chemistry at Northeastern University in 1969, was appointed Matthews Distinguished Professor in1980, and was a Fulbright Scholar from 1975 to 1976. Dr. Neumeyer is a fellow of the American Association for the...

Sarah L. Withey, PhD

Sarah L. Withey, PhD, is an instructor in psychiatry at Harvard Medical School and an assistant psychobiologist in the Preclinical Pharmacology Program at McLean Hospital. Her research focuses on elucidating the pharmacological mechanisms that mediate the behavioral effects of drugs of abuse. Dr. Withey received her PhD at the University of Bristol, UK, in May 2015. Her thesis focused on the...